Entweder 10000% oder Totalverlust
wichtig ist was heute passiert, und das der kursverfall nicht weitergeht.
Ansonsten denke ich das wir sehr bald die 0,10 cent nachhaltig knacken, um dann endlich wieder richtung 0,20 zu laufen.
gruß grenke
Gruß masteruz
Das darf doch alles nicht wahr sein? Aber Calypte kaufen......*kopfschüttelvorungläubigkeit*
So long,
Calexa
www.investorweb.de
Na gut ich setz es trozdem mal rein,alles gute weiterhin
gruß grenke
Calypte Biomedical to Present at the Wall Street Analyst Forum 47Th Annual Institutional Investor Conference
ALAMEDA, Calif., Feb 5, 2003 (BUSINESS WIRE) -- Calypte Biomedical Corporation (OTCBB:CALY), the developer and marketer of the only two FDA approved HIV-1 antibody tests that can be used on urine samples, as well as an FDA approved serum HIV-1 antibody Western blot supplemental test, today announced that it will be presenting at the Wall Street Analyst Forum 47th Institutional Investor Conference at The Roosevelt Hotel in New York City, New York on Monday, February 10, 2003 at 9:00 a.m. ET.
Presenting for Calypte will be Tony Cataldo, chairman and Nancy Katz, president and CEO. The webcast presentation will also be broadcast over the Internet. To listen to the presentation, please go to the investor's section of Calypte's web site at www.calypte.com and register for the webcast presentation. An archived replay will be available after the conclusion of the presentation for 30 days.
About Calypte Biomedical:
Calypte Biomedical Corporation headquartered in Alameda, California, is a public healthcare company dedicated to the development and commercialization of urine-based diagnostic products and services for Human Immunodeficiency Virus Type 1 (HIV-1), sexually transmitted diseases and other infectious diseases. Calypte's tests include the screening EIA and supplemental Western Blot tests, the only two FDA-approved HIV-1 antibody tests that can be used on urine samples. The company believes that accurate, non-invasive urine-based testing methods for HIV and other infectious diseases may make important contributions to public health by helping to foster an environment in which testing may be done safely, economically, and painlessly. Calypte markets its products in countries worldwide through international distributors and strategic partners. Current product labeling including specific product performance claims can be found on our website at www.calypte.com.
CONTACT: Calypte Biomedical Corporation
Nancy Katz, 510/749-5100
nkatz@calypte.com
or
Lippert/Heilshorn & Associates
Brendan Lahiff/Kirsten Chapman, 415/433-3777 (IR)
brendan@lhai-sf.com
URL: http://www.businesswire.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
Copyright (C) 2003 Business Wire. All rights reserved.
Gruß masteruz
P.S.: Danke grenke für deine Unterstützung!!!
wenn die nur auf 1€ gehen sind das schlappe 10.000 €urolein auf die tatzte, und ich denke bei 1€ ist da noch lange nicht schluß sollten die die Finanzierung stehen haben.
gruß grenke
WESTON, FL, Feb. 05, 2003 (INTERNET WIRE via COMTEX) -- Keep an eye on Elgrande.com Inc. (OTC BB: EGND). EGND has just released major news that the Company's excellent performance has led to an Exclusive North America wide Representation Agreement with a major manufacturer! Other stock market standouts include: International BioChemical Industries (OTC BB: IBCL): Market Underperform, down 20% on 19 million shares, Rambus Inc. (NASDAQ: RMBS): Market Underperform, down 4% on 14 million shares, Calypte Biomedical Corp. (OTC BB: CALY): Market Outperform, down 19% on 9 million shares.
Denke da ist jetzt recht schnell mit einer endscheidung zu rechnen.
grenke
Gruß masteruz
Gruß masteruz